EVERETT, Wash.--(BUSINESS WIRE)--SNBL is pleased to announce it has received a response from the U.S. Food and Drug Administration (FDA) regarding the FDA’s September 2011 follow-up and general surveillance inspections. As expected, the inspection results indicate that SNBL USA has remedied all process deficiencies specified in the warning letter.
